Global Breast Cancer Monoclonal Antibodies Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 153 pages | ID: G9B183CA7ABEN
GlobalInfoResearch

Abstracts

Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells.
Scope of the Report

This report studies the Breast Cancer Monoclonal Antibodies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Breast Cancer Monoclonal Antibodies market by product type and applications/end industries.
The breast cancer monoclonal antibodies (mAbs) market is one of the fastest-growing segments of the global mAbs market and has gained major research significance among biotech and pharmaceutical companies due to the presence of high unmet needs in this area. Antibodies are increasingly becoming the best choice to treat cancers, including breast cancer. The use of antibody-drug conjugates (ADCs),including radioimmunotherapy and antibody-directed enzyme prodrug therapy, is increasing rapidly. ADCs are highly effective cytotoxic drugs linked to mAbs. These drugs have shown to be potent and efficient in treating breast cancer. This has propelled vendors to focus on novel technologies such as Seattle Genetics (SGEN), ImmunoGen (IMGN), and Immunomedics (IMMU). The rising use of these antibodies in drug development increases revenue generation in the breast cancer mAbs market, contributing to market growth.
The breast cancer mAbs market in APAC will witness a high growth rate during the forecast period due to the better market penetration of breast cancer mAbs and biosimilars in emerging economies, especially in Japan, Australia, India, South Korea, and China. The rising number of initiatives undertaken by major vendors to assist patients in these countries is a significant contributor to the rise in sales of breast cancer mAbs in these countries. Moreover, the growing awareness about breast cancer and the available treatment alternatives will also propel growth prospects for the market growth in APAC.
The global Breast Cancer Monoclonal Antibodies market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Breast Cancer Monoclonal Antibodies.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Amgen
• Roche
• Mylan
• Array BioPharma
• Biocad
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celldex Therapeutics
• Celltrion
• Daiichi Sankyo
• GlaxoSmithKline
• Immunomedics
• MacroGenics
• Merck
• Novartis
• Oncothyreon
• Pfizer
• Puma Biotechnology
• Seattle Genetics
• Sun Pharmaceutical Industries
• Synta Pharmaceuticals
• Teva Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Naked MAbs
• Conjugated MAbs

Market Segment by Applications, can be divided into

• Hospitals
• Retail Pharmacies
• Others

Contents

1 BREAST CANCER MONOCLONAL ANTIBODIES MARKET OVERVIEW

1.1 Product Overview and Scope of Breast Cancer Monoclonal Antibodies
1.2 Classification of Breast Cancer Monoclonal Antibodies by Types
  1.2.1 Global Breast Cancer Monoclonal Antibodies Revenue Comparison by Types (2017-2023)
  1.2.2 Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Types in 2017
  1.2.3 Naked MAbs
  1.2.4 Conjugated MAbs
1.3 Global Breast Cancer Monoclonal Antibodies Market by Application
  1.3.1 Global Breast Cancer Monoclonal Antibodies Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Retail Pharmacies
  1.3.4 Others
1.4 Global Breast Cancer Monoclonal Antibodies Market by Regions
  1.4.1 Global Breast Cancer Monoclonal Antibodies Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Breast Cancer Monoclonal Antibodies Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Breast Cancer Monoclonal Antibodies Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breast Cancer Monoclonal Antibodies Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Breast Cancer Monoclonal Antibodies Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breast Cancer Monoclonal Antibodies Status and Prospect (2013-2023)
1.5 Global Market Size of Breast Cancer Monoclonal Antibodies (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Amgen
  2.1.1 Business Overview
  2.1.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Amgen Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
  2.2.1 Business Overview
  2.2.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Roche Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.3 Mylan
  2.3.1 Business Overview
  2.3.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Mylan Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.4 Array BioPharma
  2.4.1 Business Overview
  2.4.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Array BioPharma Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biocad
  2.5.1 Business Overview
  2.5.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Biocad Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
  2.6.1 Business Overview
  2.6.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
  2.7.1 Business Overview
  2.7.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.8 Celldex Therapeutics
  2.8.1 Business Overview
  2.8.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Celldex Therapeutics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.9 Celltrion
  2.9.1 Business Overview
  2.9.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Celltrion Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.10 Daiichi Sankyo
  2.10.1 Business Overview
  2.10.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Daiichi Sankyo Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline
  2.11.1 Business Overview
  2.11.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 GlaxoSmithKline Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.12 Immunomedics
  2.12.1 Business Overview
  2.12.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Immunomedics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.13 MacroGenics
  2.13.1 Business Overview
  2.13.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 MacroGenics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.14 Merck
  2.14.1 Business Overview
  2.14.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Merck Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.15 Novartis
  2.15.1 Business Overview
  2.15.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Novartis Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.16 Oncothyreon
  2.16.1 Business Overview
  2.16.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Oncothyreon Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pfizer
  2.17.1 Business Overview
  2.17.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 Pfizer Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.18 Puma Biotechnology
  2.18.1 Business Overview
  2.18.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 Puma Biotechnology Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.19 Seattle Genetics
  2.19.1 Business Overview
  2.19.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.19.2.1 Product A
    2.19.2.2 Product B
  2.19.3 Seattle Genetics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.20 Sun Pharmaceutical Industries
  2.20.1 Business Overview
  2.20.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.20.2.1 Product A
    2.20.2.2 Product B
  2.20.3 Sun Pharmaceutical Industries Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.21 Synta Pharmaceuticals
  2.21.1 Business Overview
  2.2.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.21.2.1 Product A
    2.21.2.2 Product B
  2.21.3 Synta Pharmaceuticals Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
2.22 Teva Pharmaceuticals
  2.22.1 Business Overview
  2.22.2 Breast Cancer Monoclonal Antibodies Type and Applications
    2.22.2.1 Product A
    2.22.2.2 Product B
  2.22.3 Teva Pharmaceuticals Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES MARKET COMPETITION, BY PLAYERS

3.1 Global Breast Cancer Monoclonal Antibodies Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Breast Cancer Monoclonal Antibodies Players Market Share
  3.2.2 Top 10 Breast Cancer Monoclonal Antibodies Players Market Share
3.3 Market Competition Trend

4 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES MARKET SIZE BY REGIONS

4.1 Global Breast Cancer Monoclonal Antibodies Revenue and Market Share by Regions
4.2 North America Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
4.3 Europe Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
4.5 South America Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BREAST CANCER MONOCLONAL ANTIBODIES REVENUE BY COUNTRIES

5.1 North America Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
5.2 USA Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
5.3 Canada Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
5.4 Mexico Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)

6 EUROPE BREAST CANCER MONOCLONAL ANTIBODIES REVENUE BY COUNTRIES

6.1 Europe Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
6.2 Germany Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
6.3 UK Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
6.4 France Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
6.5 Russia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
6.6 Italy Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BREAST CANCER MONOCLONAL ANTIBODIES REVENUE BY COUNTRIES

7.1 Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
7.2 China Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
7.3 Japan Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
7.4 Korea Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
7.5 India Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BREAST CANCER MONOCLONAL ANTIBODIES REVENUE BY COUNTRIES

8.1 South America Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
8.2 Brazil Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
8.3 Argentina Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
8.4 Colombia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BREAST CANCER MONOCLONAL ANTIBODIES BY COUNTRIES

9.1 Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
9.2 Saudi Arabia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
9.3 UAE Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
9.4 Egypt Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
9.5 Nigeria Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
9.6 South Africa Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)

10 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES MARKET SEGMENT BY TYPE

10.1 Global Breast Cancer Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Global Breast Cancer Monoclonal Antibodies Market Forecast by Type (2018-2023)
10.3 Naked MAbs Revenue Growth Rate (2013-2023)
10.4 Conjugated MAbs Revenue Growth Rate (2013-2023)

11 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES MARKET SEGMENT BY APPLICATION

11.1 Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Application (2013-2018)
11.2 Breast Cancer Monoclonal Antibodies Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)

12 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES MARKET SIZE FORECAST (2018-2023)

12.1 Global Breast Cancer Monoclonal Antibodies Market Size Forecast (2018-2023)
12.2 Global Breast Cancer Monoclonal Antibodies Market Forecast by Regions (2018-2023)
12.3 North America Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
12.4 Europe Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
12.6 South America Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Breast Cancer Monoclonal Antibodies Picture
Table Product Specifications of Breast Cancer Monoclonal Antibodies
Table Global Breast Cancer Monoclonal Antibodies and Revenue (Million USD) Market Split by Product Type
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Types in 2017
Figure Naked MAbs Picture
Figure Conjugated MAbs Picture
Table Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Application (2013-2023)
Figure Breast Cancer Monoclonal Antibodies Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Retail Pharmacies Picture
Figure Others Picture
Table Global Market Breast Cancer Monoclonal Antibodies Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Breast Cancer Monoclonal Antibodies Type and Applications
Table Amgen Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Breast Cancer Monoclonal Antibodies Type and Applications
Table Roche Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Breast Cancer Monoclonal Antibodies Type and Applications
Table Mylan Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Array BioPharma Basic Information, Manufacturing Base and Competitors
Table Array BioPharma Breast Cancer Monoclonal Antibodies Type and Applications
Table Array BioPharma Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Biocad Basic Information, Manufacturing Base and Competitors
Table Biocad Breast Cancer Monoclonal Antibodies Type and Applications
Table Biocad Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Type and Applications
Table Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Type and Applications
Table Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table Celldex Therapeutics Breast Cancer Monoclonal Antibodies Type and Applications
Table Celldex Therapeutics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Celltrion Basic Information, Manufacturing Base and Competitors
Table Celltrion Breast Cancer Monoclonal Antibodies Type and Applications
Table Celltrion Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Breast Cancer Monoclonal Antibodies Type and Applications
Table Daiichi Sankyo Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Breast Cancer Monoclonal Antibodies Type and Applications
Table GlaxoSmithKline Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Immunomedics Basic Information, Manufacturing Base and Competitors
Table Immunomedics Breast Cancer Monoclonal Antibodies Type and Applications
Table Immunomedics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table MacroGenics Basic Information, Manufacturing Base and Competitors
Table MacroGenics Breast Cancer Monoclonal Antibodies Type and Applications
Table MacroGenics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Breast Cancer Monoclonal Antibodies Type and Applications
Table Merck Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Breast Cancer Monoclonal Antibodies Type and Applications
Table Novartis Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Oncothyreon Basic Information, Manufacturing Base and Competitors
Table Oncothyreon Breast Cancer Monoclonal Antibodies Type and Applications
Table Oncothyreon Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Breast Cancer Monoclonal Antibodies Type and Applications
Table Pfizer Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Puma Biotechnology Basic Information, Manufacturing Base and Competitors
Table Puma Biotechnology Breast Cancer Monoclonal Antibodies Type and Applications
Table Puma Biotechnology Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table Seattle Genetics Breast Cancer Monoclonal Antibodies Type and Applications
Table Seattle Genetics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Industries Breast Cancer Monoclonal Antibodies Type and Applications
Table Sun Pharmaceutical Industries Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Synta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synta Pharmaceuticals Breast Cancer Monoclonal Antibodies Type and Applications
Table Synta Pharmaceuticals Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Breast Cancer Monoclonal Antibodies Type and Applications
Table Teva Pharmaceuticals Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2017)
Table Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Players (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue Share by Players (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Share by Players in 2016
Figure Global Breast Cancer Monoclonal Antibodies Revenue Share by Players in 2017
Figure Global Top 5 Players Breast Cancer Monoclonal Antibodies Revenue Market Share in 2017
Figure Global Top 10 Players Breast Cancer Monoclonal Antibodies Revenue Market Share in 2017
Figure Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Regions (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Regions (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Regions (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Regions in 2017
Figure North America Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure South America Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table North America Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Table North America Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure USA Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Canada Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Mexico Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Europe Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Countries (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Germany Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure UK Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure France Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Russia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Italy Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure China Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Japan Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Korea Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure India Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table South America Breast Cancer Monoclonal Antibodies Revenue by Countries (2013-2018)
Table South America Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Brazil Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Argentina Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Colombia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure UAE Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Egypt Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure Nigeria Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Figure South Africa Breast Cancer Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) by Type (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Share by Type in 2017
Table Global Breast Cancer Monoclonal Antibodies Revenue Forecast by Type (2018-2023)
Figure Global Breast Cancer Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
Figure Global Naked MAbs Revenue Growth Rate (2013-2018)
Figure Global Conjugated MAbs Revenue Growth Rate (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue by Application (2013-2018)
Table Global Breast Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Share by Application (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Share by Application in 2017
Table Global Breast Cancer Monoclonal Antibodies Revenue Forecast by Application (2018-2023)
Figure Global Breast Cancer Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Breast Cancer Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
Figure Europe Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
Figure South America Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Breast Cancer Monoclonal Antibodies Revenue Market Forecast (2018-2023)